293 related articles for article (PubMed ID: 22469291)
1. SUBMIT: Systemic therapy with or without up front surgery of the primary tumor in breast cancer patients with distant metastases at initial presentation.
Ruiterkamp J; Voogd AC; Tjan-Heijnen VC; Bosscha K; van der Linden YM; Rutgers EJ; Boven E; van der Sangen MJ; Ernst MF;
BMC Surg; 2012 Apr; 12():5. PubMed ID: 22469291
[TBL] [Abstract][Full Text] [Related]
2. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.
Touboul E; Buffat L; Belkacémi Y; Lefranc JP; Uzan S; Lhuillier P; Faivre C; Huart J; Lotz JP; Antoine M; Pène F; Blondon J; Izrael V; Laugier A; Schlienger M; Housset M
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):25-38. PubMed ID: 9989511
[TBL] [Abstract][Full Text] [Related]
3. Outcome of postmastectomy radiotherapy after primary systemic treatment in patients with clinical T1-2N1 breast cancer.
Cao L; Ou D; Shen KW; Cai G; Cai R; Xu F; Zhao SG; Xu C; Grellier Adedjouma N; Kirova YM; Chen JY
Cancer Radiother; 2018 Feb; 22(1):38-44. PubMed ID: 29306555
[TBL] [Abstract][Full Text] [Related]
4. Locoregional recurrence of breast cancer following mastectomy: always a fatal event? Results of univariate and multivariate analysis.
Willner J; Kiricuta IC; Kölbl O
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):853-63. PubMed ID: 9128962
[TBL] [Abstract][Full Text] [Related]
5. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
6. Who should not undergo breast conservation?
Nijenhuis MV; Rutgers EJ
Breast; 2013 Aug; 22 Suppl 2():S110-4. PubMed ID: 24074770
[TBL] [Abstract][Full Text] [Related]
7. Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial.
Badwe R; Hawaldar R; Nair N; Kaushik R; Parmar V; Siddique S; Budrukkar A; Mittra I; Gupta S
Lancet Oncol; 2015 Oct; 16(13):1380-8. PubMed ID: 26363985
[TBL] [Abstract][Full Text] [Related]
8. A randomized controlled trial comparing primary tumour resection plus systemic therapy with systemic therapy alone in metastatic breast cancer (PRIM-BC): Japan Clinical Oncology Group Study JCOG1017.
Shien T; Nakamura K; Shibata T; Kinoshita T; Aogi K; Fujisawa T; Masuda N; Inoue K; Fukuda H; Iwata H
Jpn J Clin Oncol; 2012 Oct; 42(10):970-3. PubMed ID: 22833684
[TBL] [Abstract][Full Text] [Related]
9. Surgical Resection of the Primary Tumor in Women With De Novo Stage IV Breast Cancer: Contemporary Practice Patterns and Survival Analysis.
Lane WO; Thomas SM; Blitzblau RC; Plichta JK; Rosenberger LH; Fayanju OM; Hyslop T; Hwang ES; Greenup RA
Ann Surg; 2019 Mar; 269(3):537-544. PubMed ID: 29227346
[TBL] [Abstract][Full Text] [Related]
10. Impact of breast surgery on survival in patients with distant metastases at initial presentation: a systematic review of the literature.
Ruiterkamp J; Voogd AC; Bosscha K; Tjan-Heijnen VC; Ernst MF
Breast Cancer Res Treat; 2010 Feb; 120(1):9-16. PubMed ID: 20012891
[TBL] [Abstract][Full Text] [Related]
11. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study.
van Maaren MC; de Munck L; de Bock GH; Jobsen JJ; van Dalen T; Linn SC; Poortmans P; Strobbe LJA; Siesling S
Lancet Oncol; 2016 Aug; 17(8):1158-1170. PubMed ID: 27344114
[TBL] [Abstract][Full Text] [Related]
12. Randomized Trial Comparing Resection of Primary Tumor with No Surgery in Stage IV Breast Cancer at Presentation: Protocol MF07-01.
Soran A; Ozmen V; Ozbas S; Karanlik H; Muslumanoglu M; Igci A; Canturk Z; Utkan Z; Ozaslan C; Evrensel T; Uras C; Aksaz E; Soyder A; Ugurlu U; Col C; Cabioglu N; Bozkurt B; Uzunkoy A; Koksal N; Gulluoglu BM; Unal B; Atalay C; Yıldırım E; Erdem E; Salimoglu S; Sezer A; Koyuncu A; Gurleyik G; Alagol H; Ulufi N; Berberoglu U; Dulger M; Cengiz O; Sezgin E; Johnson R
Ann Surg Oncol; 2018 Oct; 25(11):3141-3149. PubMed ID: 29777404
[TBL] [Abstract][Full Text] [Related]
13. The Impact of Locoregional Treatment on Survival in Patients With Metastatic Breast Cancer: A National Cancer Database Analysis.
Kim KN; Qureshi MM; Huang D; Ko NY; Cassidy M; Oshry L; Hirsch AE
Clin Breast Cancer; 2020 Apr; 20(2):e200-e213. PubMed ID: 32089454
[TBL] [Abstract][Full Text] [Related]
14. Ipsilateral breast tumor recurrence as a predictor of distant disease: implications for systemic therapy at the time of local relapse.
Haffty BG; Reiss M; Beinfield M; Fischer D; Ward B; McKhann C
J Clin Oncol; 1996 Jan; 14(1):52-7. PubMed ID: 8558220
[TBL] [Abstract][Full Text] [Related]
15. Internal mammary node irradiation neither decreases distant metastases nor improves survival in stage I and II breast cancer.
Fowble B; Hanlon A; Freedman G; Nicolaou N; Hoffman J; Sigurdson E; Boraas M; Torosian M; Goldstein L
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):883-94. PubMed ID: 10863056
[TBL] [Abstract][Full Text] [Related]
16. Surgery of the primary tumor does not improve survival in stage IV breast cancer.
Dominici L; Najita J; Hughes M; Niland J; Marcom P; Wong YN; Carter B; Javid S; Edge S; Burstein H; Golshan M
Breast Cancer Res Treat; 2011 Sep; 129(2):459-65. PubMed ID: 21713372
[TBL] [Abstract][Full Text] [Related]
17. Surgery of primary tumour has survival benefit in metastatic breast cancer with single-organ metastasis, especially bone.
Rhu J; Lee SK; Kil WH; Lee JE; Nam SJ
ANZ J Surg; 2015 Apr; 85(4):240-4. PubMed ID: 25996008
[TBL] [Abstract][Full Text] [Related]
18. Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer.
Powles TJ; Hickish TF; Makris A; Ashley SE; O'Brien ME; Tidy VA; Casey S; Nash AG; Sacks N; Cosgrove D
J Clin Oncol; 1995 Mar; 13(3):547-52. PubMed ID: 7884414
[TBL] [Abstract][Full Text] [Related]
19. Surgical resection of the primary tumour is associated with improved survival in patients with distant metastatic breast cancer at diagnosis.
Ruiterkamp J; Ernst MF; van de Poll-Franse LV; Bosscha K; Tjan-Heijnen VC; Voogd AC
Eur J Surg Oncol; 2009 Nov; 35(11):1146-51. PubMed ID: 19398188
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of extracranial stereotactic body radiation therapy (SBRT) added to standard treatment in patients with solid tumors (breast, prostate and non-small cell lung cancer) with up to 3 bone-only metastases: study protocol for a randomised phase III trial (STEREO-OS).
Thureau S; Marchesi V; Vieillard MH; Perrier L; Lisbona A; Leheurteur M; Tredaniel J; Culine S; Dubray B; Bonnet N; Asselain B; Salleron J; Faivre JC
BMC Cancer; 2021 Feb; 21(1):117. PubMed ID: 33541288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
